DNA microarray analyses of genes regulated during the differentiation of embryonic stem cells

Molecular Reproduction and Development

Volumn 56, Issue 2, 2000, Pages 113-123

  Kelly, David L ^a   Rizzino, Angie ^a  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

cDNA microarray; Development; Differentiation; Embryonic stem cells; Mammalian embryogenesis; Retinoic acid

Indexed keywords

CELL DNA; COMPLEMENTARY DNA; CYTOSKELETON PROTEIN; GROWTH FACTOR; GROWTH FACTOR RECEPTOR; MEMBRANE ANTIGEN; RETINOIC ACID; SCLEROPROTEIN; TRANSCRIPTION FACTOR;

ANALYTIC METHOD; ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DNA DETERMINATION; EMBRYO DEVELOPMENT; GENE CONTROL; GENE EXPRESSION REGULATION; GENE FUNCTION; INNER CELL MASS; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATOR GENE; STEM CELL; UNINDEXED SEQUENCE;

ANIMALS; CELL DIFFERENTIATION; GENE EXPRESSION REGULATION; HUMANS; MICE; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; STEM CELLS;

ANIMALIA; MAMMALIA;

EID: 0034070944     PISSN: 1040452X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2795(200006)56:2<113::AID-MRD1>3.0.CO;2-Q     Document Type: Article

References (83)

1. Afonso S, Romagnano L, Babiarz B. 1997. The expression and function of cystatin C and cathepsin B and cathepsin L during mouse embryo implantation and placentation. Development 124:3415-3425.
2. Arsura M, Introna M, Passerini F, Mantovani A, Golay J. 1992. B-myb antisense oligonucleotides inhibit proliferation of human hematopoietic cell lines. Blood 79:2708-2716.
3. Ben-Yosef T, Yanuka O, Halle D, Benvenisty N. 1998. Involvement of Myc targets in c-myc and N-myc induced human tumors. Oncogene 17:165-171.
4. Benz CC, O'Hagan RC, Richter B, Scott GK, Chang CH, Xiong X, Chew K, Ljung BM, Edgerton S, Thor A, Hassell JA. 1997. HER2/Neu and Ets transcription activator PEA3 are coordinately upregulated in human breast cancer. Oncogene 15:1513-1525.
5. Brehm A, Ohbo K, Schöler HR. 1998. Oct-4: more than just a POUerful marker of the mammalian germline? APMIS 106:114-124.
6. Brown LA, Amores A, Schilling TF, Jowett T, Baert JL, de Launoit Y, Sharrocks AD. 1998. Molecular characterization of the zebrafish PEA3 ETS-domain transcription factor. Oncogene 17:93-104.
7. Cheatham B, Kahn CR. 1995. Insulin action and the insulin signaling network. Endocr Rev 16:117-142.
8. S6k. Proc Natl Acad Sci USA 92:11696-11700.
9. Chen JH, Vercamer C, Li Z, Paulin D, Vandenbunder B, Stehelin D. 1996. PEA3 transactivates vimentin promoter in mammary epithelial and tumor cells. Oncogene 13:1667-1675.
10. Chotteau-Lelievre A, Desbiens X, Pelczar H, Defossez PA, de Launoit Y. 1997. Differential expression patterns of the PEA3 group transcription factors through murine embryonic development. Oncogene 15:937-952.
11. Dale EC, Yang X, Moore SK, Shyamala G. 1997. Murine 86-kDa heat shock protein gene and promoter. Cell Stress Chaperones 2:87-93.
12. Dechiara TM, Efstratiadis A, Robertson EJ. 1990. A growth-deficiency phenotype in heterozygous mice carrying an insulin-like growth factor II gene disrupted by targeting. Nature 345:78-80.
13. DeGregori J, Kowalik T, Nevins JR. 1995. Cellular targets for activation by the E2F1 transcription factor include DNA synthesis- and G1/S-regulatory genes. Mol Cell Biol 15:4215-4224.
14. DeRisi J, Penland L, Brown PO, Bittner ML, Meltzer PS, Ray M, Chen Y, Su YA, Trent JM. 1996. Use of a cDNA microarray to analyse gene expression patterns in human cancer. Nat Genet 14:457-460.
15. Duffy MJ. 1996. Proteases as prognostic markers in cancer. Clin Cancer Res 2:613-618.
16. Eisen MB, Spellman PT, Brown PO, Botstein D. 1998. Cluster analysis and display of genome-wide expression patterns. Proc Natl Acad Sci USA 95:14863-14868.
17. Evans MJ, Kaufman MH. 1981. Establishment or culture of pluripotential cell from mouse embryos. Nature 292:154-156.
18. Evans RM. 1998. Vimentin: the conundrum of the intermediate filament gene family. BioEssays 20:79-86.
19. Feldman R, Poueymirou W, Papaiannou VE, DeChiara TM, Goldfarb M. 1995. Requirement of FGF-4 for postimplantation mouse development. Science 267:246-249.
20. Flaumenhaft R, Kojima S, Abe M, Rifkin DB. 1993. Activation of latent transforming growth factor β. Adv Pharmacol 24:51-76.
21. Fodor SP, Rava RP, Huang XC, Pease AC, Holmes CP, Adams CL. 1993. Multiplexed biochemical assays with biological chips. Nature 364: 555-556.
22. Fuller GN, Rhee CH, Hess KR, Caskey LS, Wang R, Bruner JM, Yung WKA, Zhang W. 1999. Reactivation of insulin-like growth factor binding protein 2 expression in glioblastoma multiforme: A revelation by parallel gene expression profiling. Cancer Res 59:4228-4232.
23. Gomez-Marquez J, Rodriguez P. 1998. Prothymosin alpha is a chromatin-remodelling protein in mammalian cells. Biochem J 333:1-3.
24. Gress TM, Hoheisel JD, Lennon GG, Zehetner G, Lehrach H. 1992. Hybridization fingerprinting of high-density cDNA-library arrays with cDNA pools derived from whole tissues. Mamm Genome 3:609-619.
25. Grover A, Oshima RG, Adamson E. 1983. Epithelial layer formation in differentiating aggregates of F9 embryonal carcinoma cells. J Biol Chem 96:1690-1696.
26. Hamilton RT, Bruns KA, Delgado MA, Shim JK, Fang Y, Denhardt DT, Nilsen-Hamilton M. 1991. Developmental expression of cathepsin L and c-rasHa in the mouse placenta. Mol Reprod Dev 30:285-292.
27. Heath JK, Smith AG. 1988. Regulatory factors of embryonic stem cells. J Cell Sci Suppl 10:257-266.
28. Hoch RV, Thompson DA, Baker RJ, Weigel RJ. 1999. GATA-3 is expressed in association with estrogen receptor in breast cancer. Int J Cancer 84:122-128.
29. Huang F, Adelman J, Jiang H, Goldstein NI, Fisher PB. 1999. Identification and temporal expression pattern of genes modulated during irreversible growth arrest and terminal differentiation in human melanoma cells. Oncogene 18:3546-3552.
30. Iyer VR, Eisen MB, Ross DT, Schuler G, Moore T, Lee JCF, Trent JM, Staudt LM, Hudson J Jr, Boguski MS, Lashkari D, Shalon D, Botstein D, Brown PO. 1999. The transcriptional program in the response of human fibroblasts to serum. Science 283:83-87.
31. Janulis M, Silberman S, Ambegaokar A, Gutkind JS, Schultz RM. 1999. Role of mitogen-activate protein kinases and c-jun/AP-1 trans-activating activity in the regulation of protease mRNAs and the malignant phenotype in NIH 3T3 fibroblasts. J Biol Chem 274:801-813.
32. Kamano H, Klempnauer K-H. 1997. B-Myb and cyclin D1 mediate heat shock element dependent activation of the human HSP70 promoter. Oncogene 14:1223-1229.
33. Karetsou Z, Sandaltzopoulos R, Frangou-Lazaridis M, Lai CY, Tsolas O, Beeker PB, Papamarcaki T. 1998. Prothymosin alpha modulates the interaction of histone H1 with chromatin. Nucleic Acids Res 26:3111-3118.
34. Kelly D, Rizzino A. 1989. Inhibitory effects of transforming growth factor-β on laminin production and growth exhibited by endoderm-like cells derived from embryonal carcinoma cells. Differentiation 41:34-41.
35. Kelly D, Campbell WJ, Tiesman J, Rizzino A. 1990. Regulation and expression of transforming growth factor type-β during early mammalian development. Cytotechnology 4:227-242.
36. Lala PK, Graham CH. 1990. Mechanisms of trophoblast invasiveness and their control: the role of protease and protease inhibitors. Cancer Metastasis Rev 369-379.
37. Lam EW, Watson RJ. 1993. An E2F-binding site mediates cell-cycle regulated repression of mouse B-myb transcription. EMBO J 12: 2705-2713.
38. Lam EW, Bennett JD, Watson RJ. 1995. Cell-cycle regulation of human B-myb transcription. Gene 160:277-281.
39. Lamb KA, Rizzino A. 1998. Effects of differentiation on the transcriptional regulation of the FGF-4 gene: critical roles played by a distal enhancer. Mol Reprod Dev 51:218-224.
40. Lau MMH, Stewart CEH, Liu Z, Bhatt H, Rotwein P, Stewart CL. 1994. Loss of the imprinted IGF2/cation-independent mannose 6-phosphate receptor results in fetal overgrowth and perinatal lethality. Genes Dev 8:2953-2963.
41. Lee H-Y, Dohi DF, Kim Y-H, Walsh GL, Consoli U, Andreeff M, Dawson MI, Hong WK, Kurie JM. 1998. All-trans retinoic acid converts E2F into a transcriptional suppressor and inhibits the growth of normal human bronchial epithelial cells through a retinoic acid receptor-dependent signaling pathway. J Clin Invest 101:1012-1019.
42. Lennon GG, Lehrach H. 1991. Hybridization analyses of arrayed cDNA libraries. Trends Genet 7:314-317.
43. Leroith D, Werner H, Beitner-Johnson D, Roberts CT Jr. 1995. Molecular and cellular aspects of the insulin-like growth factor receptor. Endocr Rev 16:143-163.
44. Lutz W, Stohr M, Schurmann J, Wenzel A, Lohr A, Schwab M. 1996. Conditional expression of N-myc in human neuroblastoma cells increases expression of alpha-prothymosin and ornithine decarboxylase and accelerates progression into S-phase early after mitogenic stimulation in quiescent cells. Oncogene 13:803-812.
45. Ma Y-G, Rosfjord E, Heubert C, Wilder P, Tiesman J, Kelly D, Rizzino A. 1992. Transcriptional regulation of the murine k-FGF gene in embryonic cell lines. Dev Biol 154:45-54.
46. MacGregor TM, Copeland NG, Jenkins NA, Giguere V. 1992. The murine gene for cellular retinoic acid-binding protein type II: genomic organization, chromosomal localization, and post-transcriptional regulation by retinoic acid. J Biol Chem 267:7777-7783.
47. Marshall H, Morrison A, Studer M, Popperl H, Krumlauf R. 1996. Retinoids and Hox genes. FASEB J 10:969-978.
48. Martin CA, Ziegler LM, Napoli JL. 1990. Retinoic acid, dibutyryl-cAMP, and differentiation affect the expression of retinoic acid receptors in F9 cells. Proc Natl Acad Sci USA 87:4804-4808.
49. Martin GR. 1981. Isolation of a pluripotent cell lines from early mouse embryos cultured in medium conditioned by teratocarcinoma stem cells. Proc Natl Acad Sci USA 78:7634-7638.
50. Minucci S, Botquin V, Young IY, Dey A, Sylvester I, Zand DJ, Ohbo K, Ozato K, Schöler H. 1996. Retinoic acid-mediated down-regulation of Oct3/4 coincides with the loss of promoter occupancy in vivo. EMBO J 15:888-899.
51. Moch H, Schraml P, Bubendorf L, Mirlacher M, Kononen J, Gasser T, Mihatsch MJ, Kallioiemi OP, Sauter G. 1999. High-throughput tissue microarray analysis to evaluate genes uncovered by cDNA microarray screening in renal cell carcinoma. Am J Pathol 154:981-986.
52. Moll J, Schmid P, Sansig G, van der Putten H. 1996. The pattern of prothymosin alpha gene expression coincides with that of myc proto-oncogenes during mouse embryogenesis. Histochem J 28: 45-52.
53. Mummery CL, Feyen A, Freund E, Shen S. 1990a. Characteristics of embryonic stem cell differentiation: a comparison with two embryonal carcinoma cell lines. Cell Differ Dev 30:195-206.
54. Mummery CL, Slager H, Kruijer W, Feijen A, Freund E, Koorneef I, van den Eijnden-van Raaij AJM. 1990b. Expression of transforming growth factor β2 during the differentiation of murine embryonal carcinoma and embryonic stem cells. Dev Biol 137:161-170.
55. Nichols J, Zevnik B, Anastassiadis K, Niwa H, Klewe-Nebenius D, Chambers I, Schöler HR, Smith A. 1998. Formation of pluripotent stem cells in the mammalian embryo depends on the POU transcription factor Oct-4. Cell 95:379-391.
56. Okamoto K, Okazawa H, Okuda A, Sakai M, Muramatsu M, Hamada H. 1990. A novel octamer binding transcription factor is differentially expressed in mouse embryonic cells. Cell 60:461-472.
57. Oshima RG. 1982. Developmental expression of murine extraembryonic endodermal cytoskeletal proteins. J Biol Chem 257:3414-3421.
58. Oshima RG, Baribault H, Caulin C. 1996. Oncogenic regulation and function of keratins 8 and 18. Cancer Metastasis Rev 15:445-471.
59. Pankov R, Neznanov N, Umezawa A, Oshima RG. 1994. AP-1, ETS, and transcriptional silencers regulate retinoic acid-dependent induction of keratin 18 in embryonic cells. Mol Cell Biol 14:7744-7757.
60. Pratt MA, Langsten AW, Gudas LJ, McBurney MW. 1993. Retinoic acid fails to induce expression of Hox genes in differentiation-defective murine embryonal carcinoma cells carrying a mutant gene for alpha retinoic acid receptor. Differentiation 53:105-113.
61. Rhee CH, Hess K, Jabbur J, Ruiz M, Yang Y, Chen S, Chenchik A, Fuller GN, Zhang W. 1999. cDNA expression array reveals heterogeneous gene expression profiles in three glioblastoma cell lines. Oncogene 18:2711-2717.
62. Rittling SR, Coutinho L, Amran T, Kolbe M. 1989. AP-1/jun binding site mediate serum inducibility of the human vimentin promoter. Nucleic Acids Res 17:1619-1633.
63. Rosner MH, Vigano MA, Ozato K, Timmons PM, Poirier F, Rigby PW, Staudt LM. 1990. A POU-domain transcription factor in early stem cells and germ cells of the mammalian embryo. Nature 345:686-692.
64. Sala A, Calabretta B. 1992. Regulation of BALB/c 3T3 fibroblast proliferation by B-myb is accompanied by selective activation of cdc2 and cyclin D1 expression. Proc Natl Acad Sci USA 89:10415-10419.
65. Schena M, Shalon D, Davis RW, Brown PO. 1995. Quantitative monitoring of gene expression patterns with a complementary DNA microarray. Science 270:467-470.
66. Schöler HR, Hatzopoulus AK, Balling R, Suzuki N, Gruss P. 1989. A family of octamer-specific proteins present during mouse embryogenesis: evidence for germline-specific expression of an Oct factor. EMBO J 8:2543-2550.
67. Sehgal A, Boynton AL, Young RF, Vermeulen SS, Yonemura KS, Kohler EP, Aldape HC, Simrell CR, Murphy GP. 1998. Application of the differential hybridization of Atlas™ Human Expression Arrays technique in the identification of differentially expressed genes in human glioblastoma multiforme tumor tissue. J Surg Oncol 67:234-241.
68. Shen MM, Leder P. 1992. Leukemia inhibitory factor is expressed by the preimplantation uterus and selectively blocks primitive ectoderm formation in vitro. Dev Biol 89:8240-8244.
69. Shen S, van den Brink CE, Kruijer W, van der Saag PT. 1992. Embryonic stem cells stably transfected with mRAR beta 2-lacZ exhibit specific expression in chimeric embryos. Int J Dev Biol 36:465-476.
70. Slager HG, Lawson KA, van den Eijnden-van Raaij AJM, de Laat SW, Mummery CL. 1991. Differential localization of TGF-β2 in mouse preimplantation and early postimplantation development. Dev Biol 145:205-218.
71. Slager HG, Freund E, Buiting AMJ, Feijen A, Mummery CL. 1993. Secretion of transforming growth factor-β isoforms by embryonic stem cells: isoform and latency are dependent on direction of differentiation. J Cell Physiol 156:247-256.
72. Stewart CEH, Rotwein P. 1996. Growth, differentiation, and survival: multiple physiological functions for insulin-like growth factors. Physiol Rev 76:1005-1026.
73. Taylor JM, Dupont-Versteegden EE, Davies JD, Hassell JA, Houle JD, Gurley CM, Peterson CA. 1997. A role for the ETS domain transcription factor PEA3 in myogenic differentiation. Mol Cell Biol 17:5550-5558.
74. Tiesman J, Rizzino A. 1989. Expression and developmental regulation of the k-FGF oncogene in human and murine embryonal carcinoma cells. In Vitro Cell Dev Biol 25:1193-1198.
75. Trimble MS, Xin JH, Guy CT, Muller WJ, Hassell JA. 1993. PEA3 is overexpressed in mouse metastatic mammary adenocarcinomas. Oncogene 8:3037-3042.
76. Velcich A, Delli-Bovi P, Mansukhani A, Ziff EB, Bascilico C. 1989. Expression of the K-fgf protooncogene is repressed during the differentiation of F9 cell. Oncogene Res 5:31-37.
77. Wang K, Gan L, Jeffery E, Gayle M, Gown AM, Skelly M, Nelson PS, Ng WV, Schummer M, Hood L, Mulligan J. 1999. Monitoring gene expression profile changes in ovarian carcinomas using cDNA microarray. Gene 229:101-108.
78. st century: using gene targeting to create a cornucopia of mouse mutants possessing precise genetic modifications. Cytotechnology 11:79-99.
79. Wilder PJ, Kelly D, Brigman K, Peterson CL, Nowling T, Gao Q-S, McComb RD, Capecchi MR, Rizzino A. 1997. Inactivation of the FGF-4 gene in embryonic stem cells alters the growth and/or the survival of their early differentiated progeny. Dev Biol 192:614-629.
80. Wodicka L, Dong H, Mittmann M, Ho M-H, Lockhart DJ. 1997. Genome-wide expression monitoring in Saccharomyces cerevisiae. Nat Biotech 15:1359-1367.
81. Wu CL, Shiau AL, Lin CS. 1997. Prothymosin alpha promotes cell proliferation in NIH3T3 cells. Life Sci 61:2091-2101.
82. Yang-Yen HF, Chiu R, Karin M. 1990. Elevation of API activity during F9 cell differentiation is due to increase c-jun transcription. New Biol 2:351-361.
83. Yoshida T, Muramatsu H, Muramatsu T, Sakamoto H, Katoh O, Sugimura T, Terada M. 1988. Differential expression of two homologous and clustered oncogenes, Hst1 and Int-2, during differentiation of F9 cells. Biochem Biophys Res Commun 157:618-625.